News
Welnax BioClear is a non-invasive toenail fungus treatment device that utilizes low-level laser therapy (LLLT) to support ...
AppaNail is an ancient antifungal herbal remedy formulated as a dietary supplement to support healthy nails and feet. It ...
LOS ANGELES — Nordic Pharma and Harrow partnered to launch an authorized generic of Maxitrol, Nordic President Philip Gioia said in this Healio Video Perspective from SightLine. Gioia said the ...
MISSOULA, Mont. — The Drug Enforcement Administration held its annual Prescription Drug Take Back Day from 10 a.m - 2 p.m. today. The DEA’s National Prescription Drug Take Back Day encourages ...
FDA warning on topical finasteride: The FDA issued a warning about the topical form of finasteride (generic Propecia), often sold by telehealth companies, due to reports of serious side effects ...
The FDA issued a public alert on Tuesday concerning generic versions of a widely-used hair loss drug that is frequently distributed by popular telehealth brands like Hims and Keeps. The agency ...
The Trump administration's Section 232 investigation into pharmaceutical imports could lead to tariffs, impacting drug prices and availability. Generic drug makers, with slim profit margins ...
The United States Food and Drug Administration (FDA) has stopped the sale of copycat versions of Ozempic and Wegovy, the Type 2 diabetes drugs used for weight loss. In 2022, the FDA announced ...
THIS AFTERNOON IN NEW YORK STATE AND LOCAL LEADERS HELD A PRESS CONFERENCE ON THE IMPORTANCE OF DISCARDING UNWANTED OR UNUSED MEDICATION AND HIGHLIGHTED HOW ANONYMOUS DRUG DROP OFF BOXES ALLOW FOR ...
ROANOKE, Va. (WDBJ) - National Prescription Drug Take Back Day is Saturday, with health and law enforcement agencies working to get rid of no-longer-needed drugs. “Medications are often an ...
Robert F. Kennedy Jr. shared his 14-year struggle with heroin addiction at the Rx and Illicit Drug Summit. He emphasized the importance of personal responsibility, spiritual awakening and ...
The global vulvovaginal candidiasis treatment market is currently valued at USD 1035 million in 2023 and is anticipated to expand at a CAGR of 4.5%. Owing to the technological advances in healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results